Cargando…

Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders

Due to its unique pharmacodynamic properties of dopamine partial agonist activity, and its association with few and mild side effects, aripiprazole is a candidate atypical antipsychotic for patients with tic disorders. This open-label study compared the efficacy and tolerability of aripiprazole with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Hanik K., Lee, Joong-Sun, Paik, Kyoung-Won, Choi, Soon-Ho, Yoon, Sujung J., Kim, Jieun E., Hong, Jin Pyo
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046348/ https://www.ncbi.nlm.nih.gov/pubmed/21188439 http://dx.doi.org/10.1007/s00787-010-0154-0

Ejemplares similares

Aripiprazole-associated tic in a schizophrenia patient
por: Guo, Xieli, et al.
Publicado: (2015)

Effects of Aripiprazole and Haloperidol on Fos-like Immunoreactivity in the Prefrontal Cortex and Amygdala
por: Park, Jong-Il, et al.
Publicado: (2011)

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders
por: Cox, Joanna H, et al.
Publicado: (2016)

Tic disorders revisited: introduction of the term “tic spectrum disorders”
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2019)

Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania
por: Ostacher, Michael J, et al.
Publicado: (2015)

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
por: Racki, Valentino, et al.
Publicado: (2021)

Use of aripiprazole in an obsessive compulsive disorder case with associated motor tics
por: Alvarado Dafonte, A., et al.
Publicado: (2022)

PT648. The effects of chronic treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens
por: Tanyeri, Mehmet Hanifi, et al.
Publicado: (2016)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
por: Berman, Robert M, et al.
Publicado: (2011)

Tackle your Tics: pilot findings of a brief, intensive group-based exposure therapy program for children with tic disorders
por: Heijerman-Holtgrefe, A. P., et al.
Publicado: (2020)

Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis
por: Yang, Chun-Song, et al.
Publicado: (2015)

Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis
por: Yang, Chunsong, et al.
Publicado: (2019)

No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol
por: Bolstad, Ingeborg, et al.
Publicado: (2015)

European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents
por: Schrag, Anette, et al.
Publicado: (2018)

Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
por: Hard, Marjie L., et al.
Publicado: (2017)

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
por: Richards, Cynthia, et al.
Publicado: (2018)

Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats
por: Pan, Bo, et al.
Publicado: (2016)

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
por: Hobart, Mary, et al.
Publicado: (2019)

Internet-based guided self-help comprehensive behavioral intervention for tics (ICBIT) for youth with tic disorders: a feasibility and effectiveness study with 6 month-follow-up
por: Rachamim, Lilach, et al.
Publicado: (2020)

Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
por: Nosè, Michela, et al.
Publicado: (2009)

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder
por: Gasior, Maria, et al.
Publicado: (2017)

Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial
por: Reade, Michael C, et al.
Publicado: (2009)

Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study
por: Bond, Molly, et al.
Publicado: (2021)

Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia
por: Hard, Marjie L., et al.
Publicado: (2018)

Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study
por: Habibi, Nastaran, et al.
Publicado: (2015)

Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial
por: Ghanizadeh, Ahmad
Publicado: (2016)

OPEN DRUG TRIAL WITH HALOPERIDOL DECANOATE INJECTIONS IN SCHIZOPHRENIA
por: Varma, V.K., et al.
Publicado: (1989)

Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome
por: Gerasch, Sarah, et al.
Publicado: (2016)

The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: objectives and methods
por: Dietrich, Andrea, et al.
Publicado: (2014)

A Randomized, Open-Label Assessment of Response to Various Doses of Atomoxetine in Korean Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder
por: Cho, Soochurl, et al.
Publicado: (2011)

An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
por: Lyu, Xiao-Juan, et al.
Publicado: (2022)

The Premonitory Urge for Tics Scale in a large sample of children and adolescents: psychometric properties in a developmental context. An EMTICS study
por: Openneer, Thaïra J. C., et al.
Publicado: (2019)

Hair cortisol-a stress marker in children and adolescents with chronic tic disorders? A large European cross-sectional study
por: Buse, Judith, et al.
Publicado: (2021)

Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial
por: van der Ende, Nadinda A.M., et al.
Publicado: (2021)

Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Andrade, Chittaranjan
Publicado: (2004)

Efficacy and Tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Chavda, R.K., et al.
Publicado: (2004)

Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease—Results of a multicenter open trial
por: Kashihara, Kenichi, et al.
Publicado: (2022)

Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting
por: Di Lorenzo, Rosaria, et al.
Publicado: (2019)

A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises
por: Pae, Chi-Un, et al.
Publicado: (2014)

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)
por: Kjelby, Eirik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lb1d2l3bdq8eve9q804ifj198n